3-Pyridin-2-yl-1H-pyrazole-4-carbaldehyde
|
- $331 - $420.61
- Product name: 3-Pyridin-2-yl-1H-pyrazole-4-carbaldehyde
- CAS: 1152541-98-4
- MF: C9H7N3O
- MW: 173.17
- EINECS:
- MDL Number:MFCD08751326
- Synonyms:1H-Pyrazole-4-carboxaldehyde, 3-(2-pyridinyl)-;3-Pyridin-2-yl-1H-pyrazole-4-carbaldehyde
4 prices
Selected condition：
Brand
- Atlantic Research Chemicals
- Matrix Scientific
Package
- 1.00g
- 1g
- 1gm:
- ManufacturerAtlantic Research Chemicals
- Product numberAH00918
- Product description3-Pyridin-2-yl-1H-pyrazole-4-carbaldehyde 95
- Packaging1g
- Price$378.46
- Updated2026-05-23
- Buy
- ManufacturerAtlantic Research Chemicals
- Product numberAH00918
- Product description3-Pyridin-2-yl-1H-pyrazole-4-carbaldehyde 95%
- Packaging1gm:
- Price$420.61
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number081690
- Product description3-Pyridin-2-yl-1H-pyrazole-4-carbaldehyde 97%
- Packaging1g
- Price$331
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number081690
- Product description3-Pyridin-2-yl-1H-pyrazole-4-carbaldehyde
- Packaging1.00g
- Price$331
- Updated2026-05-18
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Atlantic Research Chemicals | AH00918 | 3-Pyridin-2-yl-1H-pyrazole-4-carbaldehyde 95 | 1g | $378.46 | 2026-05-23 | Buy |
| Atlantic Research Chemicals | AH00918 | 3-Pyridin-2-yl-1H-pyrazole-4-carbaldehyde 95% | 1gm: | $420.61 | 2021-12-16 | Buy |
| Matrix Scientific | 081690 | 3-Pyridin-2-yl-1H-pyrazole-4-carbaldehyde 97% | 1g | $331 | 2021-12-16 | Buy |
| Matrix Scientific | 081690 | 3-Pyridin-2-yl-1H-pyrazole-4-carbaldehyde | 1.00g | $331 | 2026-05-18 | Buy |
Properties
Boiling point :446.8±35.0 °C(Predicted)
Density :1.320±0.06 g/cm3(Predicted)
pka :9.01±0.50(Predicted)
Density :1.320±0.06 g/cm3(Predicted)
pka :9.01±0.50(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|